The Predicted Impact of Ipilimumab Usage on Survival in Previously Treated Advanced or Metastatic Melanoma in the UK

BACKGROUND: Evaluating long-term prognosis is important for physicians, patients and payers. This study reports the results of a model developed to predict long-term survival for UK patients receiving second-line ipilimumab. METHODS: MDX010-20 trial data were used to predict survival for ipilimumab...

Descripción completa

Detalles Bibliográficos
Autores principales: Larkin, James, Hatswell, Anthony J., Nathan, Paul, Lebmeier, Maximilian, Lee, Dawn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689358/
https://www.ncbi.nlm.nih.gov/pubmed/26700304
http://dx.doi.org/10.1371/journal.pone.0145524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689358/
https://www.ncbi.nlm.nih.gov/pubmed/26700304
http://dx.doi.org/10.1371/journal.pone.0145524

Ejemplares similares